Illumina, Inc. (NASDAQ: ILMN) and Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration to advance precision oncology ...

Illumina fundamentals are improving, with FY26 expected to return to positive growth and enable operating leverage. Find out ...

Illumina Inc. (NASDAQ:ILMN) is one of the 8 Best Quality Stocks to Buy According to Hedge Funds. Illumina Inc. (NASDAQ:ILMN) is one of the best quality stocks to buy according to hedge funds. On March ...

Labcorp Holdings (NYSE:LH) is expanding its New York footprint through the acquisition of assets and operations from Crouse Health and Lab Alliance. The company is also extending its collaboration ...

Located on the Buffalo Niagara Medical Campus and the first next-generation sequencing service provider in the region, UB's Genomics and Bioinformatics Core Facility provides high-quality services ...

Eric Green, MD, PhD, Chief Medical Officer of Illumina, was awarded the Distinguished Service Award by board members of The Genome Partnership—the nonprofit organization that has organized the ...

Rapid expansion in clinical applications, rising demand for genomic diagnostics, and increased investment in CRISPR-based ...

Stanford develops protein-to-DNA method enabling high-throughput protein sequencing Technique detects up to 1,000 times more ...

I tried the $950 blood test Silicon Valley thinks can revolutionize cancer screening. The science—and my results—tell a ...

Key opportunities include rising precision oncology adoption, increased demand for personalized therapies, integration of ...

According to the in-depth study published by MarkNtel Advisors, the Global Artificial Intelligence (AI) in Precision Medicine Market is projected to grow at a CAGR of around 31.35% during 2026-2032.

A study found that in about 10 percent of patients, WGS picked up on clinically actionable information other panels missed.